Journals / Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi / 2021 / Cilt: 35 - Sayı: 3

COVID-19 MICROBIOLOGICAL DIAGNOSTIC TESTS

COVID-19 mikrobiyolojik tanı testleri

Pages
55–69
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review we aim to provide the updated information about diagnostic methods of COVID 19 and discuss the strengths and limitations of these assays.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The knowledge of laboratory methods is essential for timely and accurate diagnosis of COVID 19 in order to identify new cases and monitor dynamics of the pandemic.
📊
Key Findings & Data:Diagnostic methods of COVID 19 can be categorized into nucleic acid detection and immunoassays for antigen or antibody detection.
💡
Conclusion & Impact:In this review we aim to provide the updated information about diagnostic methods of COVID 19 and discuss the strengths and limitations of these assays.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The knowledge of laboratory methods is essential for timely and accurate diagnosis of COVID 19 in order to identify new cases and monitor dynamics of the pandemic. Diagnostic methods of COVID 19 can be categorized into nucleic acid detection and immunoassays for antigen or antibody detection. Detection of viral RNA with real time reverse transcriptase polymerase chain reaction (RT PCR) is the gold standard method due to its high accuracy. Antigen detection tests are designed to detect viral proteins produced by replicating virus in the upper respiratory system. They are faster, associated with viral transmission risk with but less sensitive than nucleic acid assays. Antibody detection assays allow the detection of virus specific antibody responses in COVID 19 patients or vaccinated individuals and require a certain time period after exposure to the antigen. In this review we aim to provide the updated information about diagnostic methods of COVID 19 and discuss the strengths and limitations of these assays.

Özet

COVID 19 tanısının zamanında ve doğru yapılması, yeni olguları saptamak ve pandeminin dinamiklerini izlemek için gereklidir. COVID 19 tanısında kullanılan yöntemler, nükleik asid saptama testleri ve antijen veya antikor saptamaya yönelik immun testler olmak üzere ikiye ayrılabilir. Virus RNA’sının gerçek zamanlı ters transkriptaz polimeraz zincir reaksiyonu (RTPCR) ile saptanması, sağladığı yüksek doğruluk nedeniyle tanıda altın standard olarak kabul edilmektedir. Antijen saptama testleri, üst solunum yollarında replike olan virusa ait proteinleri saptamak için geliştirilmiştir. Daha hızlı ve bulaştırıcılık riski ile ilişkilidirler ancak nükleik asid testlerine göre duyarlılıkları daha düşüktür. Antikor saptama testleri COVID 19 hastalarında veya aşı olanlarda virusa spesifik antikor yanıtının belirlenmesini sağlar ve antijen ile temastan sonra belli bir süre geçmesini gerektirir. Bu derlemede, COVID 19 tanı yöntemleri hakkında güncel bilgi verilmesi ve bu testlerin güçlü yönleri ile sınırlılıklarının tartışılması amaçlanmıştır.

🔖

Cite This Article

DİNÇ, F., APAK, Ö., SAYINER, A. (2022). COVID-19 MICROBIOLOGICAL DIAGNOSTIC TESTS. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, Cilt: 35 - Sayı: 3, 55–69. https://ajindex.com/articles/492042

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Zhang Y.Z. Novel 2019 coronavirus genome. Virological org [Internet] [Erişim tarihi: 26 Ocak 2021]. Erişim adresi: http://virological.org/t/novel 2019 coronavirus genome/319
  2. The species severe acute respiratory syndrome related coronavirus: classifying 2019 nCoV and naming it SARS CoV 2. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. Nature Microbiol. 2020;5:536 44
  3. Worldometer [Internet]. [Erişim tarihi: 22 Şubat 2021]. Erişim adresi:
  4. European Centre for Disease Prevention and Control [Internet]. Options for the use of rapid antigen tests for COVID 19 in the EU/EEA and the UK 19 November 2020 [Erişim tarihi: 26 Ocak 2021]. Erişim adresi: https://www.ecdc.europa.eu/sites/default/files/docum ents/Options use of rapid antigen tests for COVID 19_0.pdf 5. Centers for Disease Control and Prevention interim guidelines [Internet]. Using Antibody Tests for COVID 19 Updated Nov. 3, 2020 [Erişim tarihi: 22 Şubat 2021]. Erişim adresi: https://www.cdc.gov/coronavirus/2019 ncov/lab/resources/antibody tests guidelines.html 6. Caruana G, Croxatto A, Coste AT, Opota O, Lamoth F, Jaton K, et al. Diagnostic strategies for SARS CoV 2 infection and interpretation of microbiological results. Clin Microbiol Infect. 2020;26:1178 82
  5. Carter LJ, Garner LV, Smoot JW, Li Y, Zhou Q, Saveson CJ, et al. Assay techniques and test development for COVID 19 diagnosis. ACS Cent Sci. 2020;6:591–605
  6. Food and Drug Administration [Internet]. In Vitro Diagnostics EUAs Molecular Diagnostic Tests for SARS CoV 2 [Erişim tarihi: 22 Şubat 2021]. Erişim adresi: https://www.fda.gov/medicaldevices/ coronavirus disease 2019 covid 19 emergency use authorizations medical devices/invitro diagnostics euas molecular diagnostic testssars cov 2 9. World Health Organization [Internet]. Coronavirus disease (COVID 19) technical guidance: Laboratory testing for 2019 nCoV in humans [Erişim tarihi: 22 Şubat 2021]. Erişim adresi: https://www.who.int/emergencies/diseases/novelcoronavirus 2019/technical guidance/laboratoryguidance/ 10. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019 nCoV) by real time RT PCR. Euro Surveill. 2020;25:2000045
  7. Watson J., Whiting P.F., Brush J.E. Interpreting a COVID 19 test result. BMJ. 2020;369:m1808
  8. Padhye N.S. Reconstructed diagnostic sensitivity and specificity of the RT PCR test for COVID 19. MedRxiv. 2020 preprint.doi: